The persistent activation of STAT3 is attributed to the disruption of negative modulators of STAT3 signaling, somatic mutations in STAT3, enhanced activity of upstream kinases, and establishment of the positive feedback loop in the tumor microenvironment [54,55,56,57]. This evidence concerns the gene STAT3 and neoplasm.